Animating Therapeutic Macrocyclic Peptide Discovery Platform

Animating Therapeutic Macrocyclic Peptide Discovery Platform

Client:

National Hellenic Research Foundation logo

NHRF conducts high-quality scientific research with the aim of contributing to scientific and technological progress. Through research activities at various Institutes, the NHRF seeks to develop and apply innovative solutions in critical fields of biology, chemistry, and physics, such as health, energy, materials, and biotechnology.

NHRF conducts high-quality scientific research with the aim of contributing to scientific and technological progress. Through research activities at various Institutes, the NHRF seeks to develop and apply innovative solutions in critical fields of biology, chemistry, and physics, such as health, energy, materials, and biotechnology.

Client:

Project Goal

Project Goal

Project Goal

The objective of this project and its accompanying animation is to depict the innovative research sponsored by the NHRF and conducted by the research group of Georgios Skretas at the Institute for Bioinnovation. This group is developing a bacterial platform for the discovery and screening of therapeutic macrocyclic peptides (macrocycles) for the potential treatment of protein aggregation–related diseases, including Parkinson’s disease, Alzheimer’s disease, and diabetes.


This approach involves the creation of bacterial libraries in which each bacterium synthesizes a distinct macrocycle that promotes the formation of specific protein aggregates. By systematically evaluating these aggregates, researchers can identify macrocycles that effectively inhibit pathological protein misfolding and aggregation—hallmarks of neurodegenerative and metabolic disorders. Promising candidates emerging from this process undergo further validation and testing as potential drug therapies, contributing to advances in disease prediction and treatment.

See full animation.

The objective of this project and its accompanying animation is to depict the innovative research sponsored by the NHRF and conducted by the research group of Georgios Skretas at the Institute for Bioinnovation. This group is developing a bacterial platform for the discovery and screening of therapeutic macrocyclic peptides (macrocycles) for the potential treatment of protein aggregation–related diseases, including Parkinson’s disease, Alzheimer’s disease, and diabetes.


This approach involves the creation of bacterial libraries in which each bacterium synthesizes a distinct macrocycle that promotes the formation of specific protein aggregates. By systematically evaluating these aggregates, researchers can identify macrocycles that effectively inhibit pathological protein misfolding and aggregation—hallmarks of neurodegenerative and metabolic disorders. Promising candidates emerging from this process undergo further validation and testing as potential drug therapies, contributing to advances in disease prediction and treatment.

See full animation.

The objective of this project and its accompanying animation is to depict the innovative research sponsored by the NHRF and conducted by the research group of Georgios Skretas at the Institute for Bioinnovation. This group is developing a bacterial platform for the discovery and screening of therapeutic macrocyclic peptides (macrocycles) for the potential treatment of protein aggregation–related diseases, including Parkinson’s disease, Alzheimer’s disease, and diabetes.


This approach involves the creation of bacterial libraries in which each bacterium synthesizes a distinct macrocycle that promotes the formation of specific protein aggregates. By systematically evaluating these aggregates, researchers can identify macrocycles that effectively inhibit pathological protein misfolding and aggregation—hallmarks of neurodegenerative and metabolic disorders. Promising candidates emerging from this process undergo further validation and testing as potential drug therapies, contributing to advances in disease prediction and treatment.

See full animation.

Visualization of the human body alongside normally folded and misfolded proteins

Visualization of the normally folded and misfolded proteins

Human brain and nervous system

Transposases active site shown as ribbons inside the molecular complex

Bacteria producing macrocyclic peptides

Bacteria producing macrocyclic peptides

“Great animations and fast turnaround - Highly recommended!”

“Great animations and fast turnaround - Highly recommended!”

“Great animations and fast turnaround - Highly recommended!”

Patrick Hsu

Director of Institute for Bio-innovation


Director of Institute for Bio-innovation


Engineered bacteria fix misfolded proteins

Engineered bacteria fix misfolded proteins

Identified Florescent Microbes

Identified Florescent Microbes

Flow Cytometric Cell Sorting

Flow Cytometric Cell Sorting

Flow Cytometric Cell Sorting

The Process

The Process

The Process

Animation type:

High-End 3D

Project timline:

7 weeks

Review:

3 zoom calls + 4 e-mail feedback sessions

Find out which of our 26 scientific animation options works best for investor relations and communications:

The animation was developed under budget constraints and a tight production timeline, requiring a cost-effective yet scientifically precise approach suitable for both academic collaborators and industry partners. To achieve this, we used high-end 3D for key molecular scenes, depicting detailed aggregates and their disintegration, with GFP proteins luminescing to highlight bacterial identification.


DECK 3D provided high visual quality and was partially based on static renders to optimize production efficiency. A semi-static 3D animation approach helped maintain scientific accuracy while remaining within budget. In addition, flow cytometric cell-sorting visualizations were incorporated to clarify the processes of selection and isolation.


Semi-Static 3D for Cost Efficiency: Instead of fully dynamic molecular animation, the core scientific visuals were created as high-fidelity, scientifically accurate static 3D renderings. Key molecular structures and cellular environments were modeled in detail but remained largely static.


Layered 2D Motion Elements: To enhance storytelling, subtle 2D animations, overlays, and informational callouts were added to highlight molecular interactions and guide viewers through the scientific process. This hybrid approach enabled a compelling narrative while optimizing production time and cost.


High-Precision Molecular Modeling for Key Scenes: While the broader visualization relied on a semi-static 3D approach, select molecular interactions were developed with detailed molecular animation and simulations, ensuring that critical scientific aspects were captured with high accuracy.


This cost-conscious strategy made it possible to deliver an animation that met rigorous scientific standards while remaining within the budgetary and time constraints of an early-stage research initiative.

Why did we use this
animation type?

Why did we use this
animation type?

By leveraging a combination of high-end 3D and DECK 3D, we ensured that the animation was both visually compelling and scientifically precise. High-end 3D brought molecular interactions to life through detailed modeling, while DECK 3D optimized rendering costs without sacrificing clarity. The integration of flow cytometric cell-sorting visualizations further enhanced the animation’s ability to communicate complex scientific concepts effectively.

This careful selection of animation techniques resulted in an engaging, informative, and cost-efficient final product.

Outcome:

The final animation successfully illustrated the scientific foundation and potential impact of the research, providing a powerful visual tool for engaging stakeholders across academia, biotechnology, and the pharmaceutical industry. This project demonstrates how early-stage research groups and non-commercial organizations can leverage scientific visualization services for pharma and biotech audiences to communicate discoveries, attract potential collaborators, and lay the groundwork for future commercialization. It also reinforces our ability to adapt animation techniques to the unique needs and budgets of academic institutions, startups, and research organizations.

By utilizing a flexible animation pipeline, similar to our work for ARC Institute, we demonstrated how even fundamental research—long before clinical trials or commercial application—can benefit from precisely designed visual storytelling that bridges the gap between scientific complexity and stakeholder engagement.

The final animation successfully illustrated the scientific foundation and potential impact of the research, providing a powerful visual tool for engaging stakeholders across academia, biotechnology, and the pharmaceutical industry. This project demonstrates how early-stage research groups and non-commercial organizations can leverage scientific visualization services for pharma and biotech audiences to communicate discoveries, attract potential collaborators, and lay the groundwork for future commercialization. It also reinforces our ability to adapt animation techniques to the unique needs and budgets of academic institutions, startups, and research organizations.

By utilizing a flexible animation pipeline, similar to our work for ARC Institute, we demonstrated how even fundamental research—long before clinical trials or commercial application—can benefit from precisely designed visual storytelling that bridges the gap between scientific complexity and stakeholder engagement.

The final animation successfully illustrated the scientific foundation and potential impact of the research, providing a powerful visual tool for engaging stakeholders across academia, biotechnology, and the pharmaceutical industry. This project demonstrates how early-stage research groups and non-commercial organizations can leverage scientific visualization services for pharma and biotech audiences to communicate discoveries, attract potential collaborators, and lay the groundwork for future commercialization. It also reinforces our ability to adapt animation techniques to the unique needs and budgets of academic institutions, startups, and research organizations.

By utilizing a flexible animation pipeline, similar to our work for ARC Institute, we demonstrated how even fundamental research—long before clinical trials or commercial application—can benefit from precisely designed visual storytelling that bridges the gap between scientific complexity and stakeholder engagement.

The final animation successfully illustrated the scientific foundation and potential impact of the research, providing a powerful visual tool for engaging stakeholders across academia, biotechnology, and the pharmaceutical industry. This project demonstrates how early-stage research groups and non-commercial organizations can leverage scientific visualization services for pharma and biotech audiences to communicate discoveries, attract potential collaborators, and lay the groundwork for future commercialization. It also reinforces our ability to adapt animation techniques to the unique needs and budgets of academic institutions, startups, and research organizations.

By utilizing a flexible animation pipeline, similar to our work for ARC Institute, we demonstrated how even fundamental research—long before clinical trials or commercial application—can benefit from precisely designed visual storytelling that bridges the gap between scientific complexity and stakeholder engagement.

Full animation

Full animation

Full animation

Contact us

/10

“Fantastic team to partner with throughout the entire process. Excellent output and management!”

Pádraig Moran

Global Marketing Director, Pfizer

/10

"Visual Science produced an excellent website with incredible imagery, working in a professional, efficient manner to create a stunning final product! They were engaged through every step of the process and were attentive to the ideas we had in mind for our website. They continue to work with us on all updates and requests in a timely and helpful manner!"

Noel Kurdi

VP, Investor Relations, Apogee Therapeutics

/10

“Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”

Bob Nichols

VP, Corp Dev, Revolution Medicines

/10

“We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.

Rosana Kapeller

President, CEO and co-founder, ROME Therapeutics

/10

“Visual Science has a unique ability to communicate complex science with both accuracy and visual impact. Their team combines scientific understanding with creativity, helping bring sophisticated biomedical concepts to life.”

Paul Peter Tak

President, CEO and Board Director, Candel Therapeutics

/10

“We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”

Michael Zasloff

CSO, Enterin

/10

“I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”

Guru Reddy

Vice President, R&D, Unicycive Therapeutics

/10

"Visual Science was a great partner in the development and delivery of scientific animations; the combination of their understanding of the science and their artistic expertise resulted in a visually stunning and impactful video."

Lynnea Waters

Director, Scientific Communications, Apogee Therapeutics

/10

“Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”

Ravi Moorthy

VP, Head of Communications, Scorpion Therapeutics

/10

“Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”

John Hanna

CEO, Apton

/10

“We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”

Patrick Ritschel

CEO, Atsena Therapeutics

/10

“The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”

Blake Aronson

Program Manager, ACS

/10

“The creativity, scientific competency and professionalism of the Visual Science team not only enabled the generation of high-quality images, but also made it a pleasure to work with them.”

Jan Smith

CSO, Biology, Revolution Medicines

/10

"Incredible animations that really help bring our science to life. I strongly recommend Visual Science!"

Josh Cirulli

VP, Medical Affairs, Apogee Therapeutics

/10

“The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”

Anirvan Ghosh

CEO, UNITY Biotechnology

/10

"We were impressed with the Visual Science team's attention to detail and ability to extract key messages out of a complex scientific story. Their deep understanding of the science enabled them to turn our cryo-EM structures into a beautiful visual that shows the key aspects of the bridge recombination mechanism."

Patrick Hsu

Co-Founder, Arc Institute · Assistant Professor, UC Berkeley

/10

"The Visual Science team did an outstanding job delivering beautiful MOA videos for us. The animations and attention to detail were exceptional, and their flexibility throughout the process made a huge difference."

Jen Do, Associate Director, External Sci Comm, AbbVie

Jen Do

Associate Director, External Sci Comm, AbbVie

/10

"Excellent work by the Visual Science team!"

Miguel Sobral

Associate Director, BD&Strategy, Apogee Therapeutics

/10

"Excellent work and project management."

Daniel Martins, Scientific Director, AbbVie

Daniel Martins

Scientific Director, AbbVie

/10

"Visual Science produces high quality animations to support our unique science with agility and speed. I do value their partnership and look forward to working on more projects with them."

Aparna Shetty, Lead, Scientific Communications and Content, Astellas

Aparna Shetty

Lead, Scientific Communications and Content, Astellas

/10

"The VS team was outstanding to work with on this project. From the outset, the level of communication, organization, and attention to detail was exceptional. The VS team moved a complication MoA project forward on-schedule, with scientific rigor, and the result was a beautifully composed video that distilled complex biology in a visually accurate way. I highly recommend this team."

Taylor Schreiber, CEO, Shattuck Labs, Inc.

Taylor Schreiber

CEO, Shattuck Labs, Inc.

/10

"Thank you very much for such a great deliverable on a very tight timeline. I have been doing things like this for a long time and your incorporation of the Atsena insights to this with a very fast turnaround is very much appreciated and impressive."

Edmund Doherty - Vice President of Medical Affairs | Clinical Strategy | Global People Leader, Atsena Therapeutics

Edmund Doherty

Vice President of Medical Affairs, Atsena Therapeutics

/10

"Very responsive and efficient. Thank you!"

Brian Padden, Asset Strategy Leader, AbbVie

Brian Padden

Asset Strategy Leader, AbbVie

Contact us

/10

“Fantastic team to partner with throughout the entire process. Excellent output and management!”

Pádraig Moran

Global Marketing Director, Pfizer

/10

"Visual Science produced an excellent website with incredible imagery, working in a professional, efficient manner to create a stunning final product! They were engaged through every step of the process and were attentive to the ideas we had in mind for our website. They continue to work with us on all updates and requests in a timely and helpful manner!"

Noel Kurdi

VP, Investor Relations, Apogee Therapeutics

/10

“Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”

Bob Nichols

VP, Corp Dev, Revolution Medicines

/10

“We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.

Rosana Kapeller

President, CEO and co-founder, ROME Therapeutics

/10

“Visual Science has a unique ability to communicate complex science with both accuracy and visual impact. Their team combines scientific understanding with creativity, helping bring sophisticated biomedical concepts to life.”

Paul Peter Tak

President, CEO and Board Director, Candel Therapeutics

/10

“We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”

Michael Zasloff

CSO, Enterin

/10

“I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”

Guru Reddy

Vice President, R&D, Unicycive Therapeutics

/10

"Visual Science was a great partner in the development and delivery of scientific animations; the combination of their understanding of the science and their artistic expertise resulted in a visually stunning and impactful video."

Lynnea Waters

Director, Scientific Communications, Apogee Therapeutics

/10

“Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”

Ravi Moorthy

VP, Head of Communications, Scorpion Therapeutics

/10

“Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”

John Hanna

CEO, Apton

/10

“We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”

Patrick Ritschel

CEO, Atsena Therapeutics

/10

“The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”

Blake Aronson

Program Manager, ACS

/10

“The creativity, scientific competency and professionalism of the Visual Science team not only enabled the generation of high-quality images, but also made it a pleasure to work with them.”

Jan Smith

CSO, Biology, Revolution Medicines

/10

"Incredible animations that really help bring our science to life. I strongly recommend Visual Science!"

Josh Cirulli

VP, Medical Affairs, Apogee Therapeutics

/10

“The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”

Anirvan Ghosh

CEO, UNITY Biotechnology

/10

"We were impressed with the Visual Science team's attention to detail and ability to extract key messages out of a complex scientific story. Their deep understanding of the science enabled them to turn our cryo-EM structures into a beautiful visual that shows the key aspects of the bridge recombination mechanism."

Patrick Hsu

Co-Founder, Arc Institute · Assistant Professor, UC Berkeley

/10

"The Visual Science team did an outstanding job delivering beautiful MOA videos for us. The animations and attention to detail were exceptional, and their flexibility throughout the process made a huge difference."

Jen Do, Associate Director, External Sci Comm, AbbVie

Jen Do

Associate Director, External Sci Comm, AbbVie

/10

"Excellent work by the Visual Science team!"

Miguel Sobral

Associate Director, BD&Strategy, Apogee Therapeutics

/10

"Excellent work and project management."

Daniel Martins, Scientific Director, AbbVie

Daniel Martins

Scientific Director, AbbVie

/10

"Visual Science produces high quality animations to support our unique science with agility and speed. I do value their partnership and look forward to working on more projects with them."

Aparna Shetty, Lead, Scientific Communications and Content, Astellas

Aparna Shetty

Lead, Scientific Communications and Content, Astellas

/10

"The VS team was outstanding to work with on this project. From the outset, the level of communication, organization, and attention to detail was exceptional. The VS team moved a complication MoA project forward on-schedule, with scientific rigor, and the result was a beautifully composed video that distilled complex biology in a visually accurate way. I highly recommend this team."

Taylor Schreiber, CEO, Shattuck Labs, Inc.

Taylor Schreiber

CEO, Shattuck Labs, Inc.

/10

"Thank you very much for such a great deliverable on a very tight timeline. I have been doing things like this for a long time and your incorporation of the Atsena insights to this with a very fast turnaround is very much appreciated and impressive."

Edmund Doherty - Vice President of Medical Affairs | Clinical Strategy | Global People Leader, Atsena Therapeutics

Edmund Doherty

Vice President of Medical Affairs, Atsena Therapeutics

/10

"Very responsive and efficient. Thank you!"

Brian Padden, Asset Strategy Leader, AbbVie

Brian Padden

Asset Strategy Leader, AbbVie

Contact us

Contact us

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

Address

200 Vesey Street, 24th floor,
New York, NY 10281, USA

Social networks

LinkedIn Logo
Vimeo Logo

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

  • The Telly Awards logo
  • Hermes Creative Awards Logo
  • The Communicator Awards logo
  • National Science Foundation logo
  • Science Magazine Logo
  • Viddy Awards Logo

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

Address

200 Vesey Street, 24th floor,
New York, NY 10281, USA

Social networks

LinkedIn Logo
Vimeo Logo

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

  • The Telly Awards logo
  • Hermes Creative Awards Logo
  • The Communicator Awards logo
  • National Science Foundation logo
  • Science Magazine Logo
  • Viddy Awards Logo

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

Address

200 Vesey Street, 24th floor,
New York, NY 10281, USA

Social networks

LinkedIn Logo
Vimeo Logo

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

  • The Telly Awards logo
  • Hermes Creative Awards Logo
  • The Communicator Awards logo
  • National Science Foundation logo
  • Science Magazine Logo
  • Viddy Awards Logo

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

Address

200 Vesey Street, 24th floor, New York, NY 10281, USA

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

  • The Telly Awards logo
  • Hermes Creative Awards Logo
  • The Communicator Awards logo
  • National Science Foundation logo
  • Science Magazine Logo
  • Viddy Awards Logo
Visual Science Logo